4//SEC Filing
Phalen Michael P. 4
Accession 0001225208-18-002898
CIK 0000885725other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:32 PM ET
Size
9.9 KB
Accession
0001225208-18-002898
Insider Transaction Report
Form 4
Phalen Michael P.
SVP & President, Endoscopy
Transactions
- Award
Common Stock
2018-02-12+24,524→ 131,443 total - Tax Payment
Common Stock
2018-02-12$26.18/sh−7,223$189,098→ 124,220 total - Award
Performance Share Units
2018-02-12+11,926→ 11,926 totalFrom: 2019-12-31Exp: 2019-12-31→ Common Stock (11,926 underlying)
Footnotes (4)
- [F1]On February 23, 2015, the reporting person was awarded a target number of performance share units under the Company's 2015 Total Shareholder Return Performance Share Program, the actual number of which to be earned by the reporting person was based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Healthcare Index over the three annual performance cycles comprising the three-year period ended December 31, 2017 and was subject to the completion of the concurrent three-year individual service period. On February 12, 2018, the number of the target performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied.
- [F2]Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- [F3]Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- [F4]On February 28, 2017, the reporting person was awarded a target number of performance share units under the Company's 2017 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2017 adjusted free cash flow measured against its 2017 financial plan over the one-year performance period ending December 31, 2017 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 12, 2018, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2019.
Documents
Issuer
BOSTON SCIENTIFIC CORP
CIK 0000885725
Entity typeother
Related Parties
1- filerCIK 0001483882
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:32 PM ET
- Size
- 9.9 KB